Evidence map›Paper›PMID 20473299›Full record

ArticleNature immunology2010

Synaptotagmin-mediated vesicle fusion regulates cell migration.

Richard A Colvin, Terry K Means, Thomas J Diefenbach, Luis F Moita, Robert P Friday, Sanja Sever, Gabriele S V Campanella, Tabitha Abrazinski, Lindsay A Manice, Catarina Moita and 4 more

Abstract read
In one paragraph

Article in Nature immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 107 citations in OpenAlex.

  1. Functional Genomics: Principles and Methods.Advances in experimental medicine and biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. CaNeuromolecular medicine · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Protrudin-mediated ER-endosome contact sites promote phagocytosis.Cellular and molecular life sciences : CMLS · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. eLife · 2020
    Article
  17. Article
  18. Therapeutic targeting of neutrophil exocytosis.Journal of leukocyte biology · 2020
    Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Richard A ColvinCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Terry K Means
Thomas J Diefenbach
Luis F Moita
Robert P Friday
Sanja Sever
Gabriele S V Campanella
Tabitha Abrazinski
Lindsay A Manice
Catarina Moita
Norma W Andrews
Dianqing Wu
Nir Hacohen
Andrew D Luster
Massachusetts General Hospital · USHarvard University · USMassachusetts Institute of Technology · USUniversity of Lisbon · PTUniversity of Maryland, College Park · USYale University · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Vascular Pathophysiology and History Core (VPHC)P01HL070694 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COWAN, ANN E. · 2002 to 2013
$17.5M
Regulated exocytosis of lysosomes and plasma membrane repairR01GM064625 · NIGMS · YALE UNIVERSITY · PI ANDREWS, NORMA WINDSOR, SONG, WENXIA · 2002 to 2020
$6.3M
Molecular Function of Chemoattractant-Mediated SignalingR01HL080706 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2005 to 2009
$2.3M
Mechanisms of anti-fungal immunity mediated by SCARF1 and CD36R01AI084884 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MEANS, TERRY K · 2010 to 2014
$2.1M
Biochemical and Genetic Dissection of Chemokine Receptor CXCR3 SignalingR01DK074449 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 2005 to 2009
$1.7M
Molecular Function of Chemoattractant-Mediated SignalingR01GM054597 · NIGMS · UNIVERSITY OF ROCHESTER · PI WU, DIANQING · 1996 to 2004
$1.2M
NHLBI NIH HHS P01 HL070694NHLBI NIH HHS R01 HL080706NIAID NIH HHS R01 AI084884NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK074449NIGMS NIH HHS R01 GM054597NIGMS NIH HHS R01 GM064625
6 · The paper itself

Abstract

Chemokines and other chemoattractants direct leukocyte migration and are essential for the development and delivery of immune and inflammatory responses. To probe the molecular mechanisms that underlie chemoattractant-guided migration, we did an RNA-mediated interference screen that identified several members of the synaptotagmin family of calcium-sensing vesicle-fusion proteins as mediators of cell migration: SYT7 and SYTL5 were positive regulators of chemotaxis, whereas SYT2 was a negative regulator of chemotaxis. SYT7-deficient leukocytes showed less migration in vitro and in a gout model in vivo. Chemoattractant-induced calcium-dependent lysosomal fusion was impaired in SYT7-deficient neutrophils. In a chemokine gradient, SYT7-deficient lymphocytes accumulated lysosomes in their uropods and had impaired uropod release. Our data identify a molecular pathway required for chemotaxis that links chemoattractant-induced calcium flux to exocytosis and uropod release.

Indexed as

AnimalsCell MovementChemokine CXCL12ChemotaxisImmunoblottingMiceMice, Inbred C57BLMice, KnockoutPolymerase Chain ReactionReceptors, CXCR4Synaptotagmin IISynaptotagminsT-LymphocytesChemokine CXCL12Receptors, CXCR4Synaptotagmin IISynaptotagminsSyt2 protein, mouseSyt5 protein, mouseSyt7 protein, mouse

Identifiers

PMID20473299
PMCPMC2951881
OpenAlexW1971081053

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.